Anti-Caspase-9 antibody [EPR18108]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(12 Publications)
Rabbit Recombinant Monoclonal Caspase-9 antibody. Suitable for IP, WB and reacts with Human, Mouse samples. Cited in 12 publications.
View Alternative Names
MCH6, CASP9, Caspase-9, CASP-9, Apoptotic protease Mch-6, Apoptotic protease-activating factor 3, ICE-like apoptotic protease 6, APAF-3, ICE-LAP6
- IP
Supplier Data
Immunoprecipitation - Anti-Caspase-9 antibody [EPR18108] (AB185719)
Caspase-9 was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate treated with staurosporine 1uM for 4 hours with ab185719 at 1/40 dilution. Western blot was performed from the immunoprecipitate using ab185719 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : HeLa whole cell lysate treated with staurosporine 10 μg (Input).
Lane 2 : ab185719 IP in HeLa whole cell lysate treated with staurosporine.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab185719 in HeLa whole cell lysate treated with staurosporine.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Caspase-9 antibody [EPR18108] (ab185719)
Predicted band size: 46 kDa
false
- WB
Lab
Western blot - Anti-Caspase-9 antibody [EPR18108] (AB185719)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : Caspase-9 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : Jurkat cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab185719 observed at 46 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab185719 was shown to specifically react with Caspase-9 when Caspase-9 knockout samples were used. Wild-type and Caspase-9 knockout samples were subjected to SDS-PAGE. ab185719 and ab8245 (loading control to GAPDH) were diluted at 1/1000 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-Caspase-9 antibody [EPR18108] (ab185719)
Predicted band size: 46 kDa
false
- WB
Lab
Western blot - Anti-Caspase-9 antibody [EPR18108] (AB185719)
False colour image of Western blot : Anti-Caspase-9 antibody [EPR18108] staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab185719 was shown to bind specifically to Caspase-9. A band was observed at 45 kDa in wild-type THP-1 cell lysates with no signal observed at this size in CASP9 knockout cell line ab276122 (knockout cell lysate ab284219). To generate this image, wild-type and CASP9 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-Caspase-9 antibody [EPR18108] (ab185719) at 1/1000 dilution
Lane 1:
Wild-type THP-1 cell lysate at 20 µg
Lane 2:
CASP9 knockout THP-1 cell lysate at 20 µg
Lane 2:
Western blot - Human CASP9 knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-casp9-knockout-thp-1-cell-line-ab276122'>ab276122</a>)
Lane 3:
HeLa cell lysate at 20 µg
Predicted band size: 46 kDa
Observed band size: 45 kDa
false
- WB
Supplier Data
Western blot - Anti-Caspase-9 antibody [EPR18108] (AB185719)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Caspase-9 antibody [EPR18108] (ab185719) at 1/1000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Human fetal heart lysate at 10 µg
Lane 3:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 46 kDa,82 kDa
Observed band size: 46 kDa
false
Exposure time: 30s
- WB
Lab
Western blot - Anti-Caspase-9 antibody [EPR18108] (AB185719)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Caspase-9 antibody [EPR18108] (ab185719) at 1/10000 dilution
Lane 1:
Untreated HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 2:
HeLa whole cell lysate treated with staurosporine 1uM for 4 hours at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 46 kDa
Observed band size: 35 kDa,37 kDa,46 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-Caspase-9 antibody [EPR18108] (AB185719)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Caspase-9 antibody [EPR18108] (ab185719) at 1/5000 dilution
Lane 1:
Human pancreas tissue lysate at 10 µg
Lane 2:
Human fetal liver tissue lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 46 kDa
Observed band size: 46 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-Caspase-9 antibody [EPR18108] (AB185719)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Caspase-9 antibody [EPR18108] (ab185719) at 1/1000 dilution
Lane 1:
Mouse heart tissue lysate at 10 µg
Lane 2:
Mouse kidney tissue lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 46 kDa
Observed band size: 37 kDa,39 kDa,49 kDa
false
Exposure time: 15s
- WB
Lab
Western blot - Anti-Caspase-9 antibody [EPR18108] (AB185719)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Caspase-9 antibody [EPR18108] (ab185719) at 1/2500 dilution
Lane 1:
Untreated NIH/3T3 (Mouse embyro fibroblast cells) whole cell lysate at 10 µg
Lane 2:
NIH/3T3 whole cell lysate treated with staurosporine 1uM for 4 hours at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 46 kDa
Observed band size: 37 kDa,39 kDa,49 kDa
false
Exposure time: 30s
Related conjugates and formulations (1)
-
Anti-Caspase-9 antibody [EPR18108] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Pakistan journal of pharmaceutical sciences 38:1632-1646 PubMed40996179
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in microbiology 15:1485667 PubMed39529669
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of advanced research 36:147-161 PubMed35127170
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 25: PubMed35039875
2022
Applications
Unspecified application
Species
Unspecified reactive species
Chinese medical journal 134:2721-2729 PubMed34732665
2021
Applications
Unspecified application
Species
Unspecified reactive species
Human cell 34:952-964 PubMed33728585
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 22:43-50 PubMed32377708
2020
Applications
Unspecified application
Species
Unspecified reactive species
eLife 8: PubMed31453805
2019
Applications
Unspecified application
Species
Unspecified reactive species
Artificial cells, nanomedicine, and biotechnology 47:2265-2273 PubMed31184221
2019
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 13:e0203991 PubMed30231080
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com